Literature DB >> 23703614

N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration.

Gangli Liu1, Pritam K Sengupta, Basem Jamal, Hsiao-Ying Yang, Meghan P Bouchie, Volkhard Lindner, Xaralabos Varelas, Maria A Kukuruzinska.   

Abstract

Oral squamous cell carcinoma (OSCC) is one of the most pernicious malignancies, but the mechanisms underlying its development and progression are poorly understood. One of the key pathways implicated in OSCC is the canonical Wnt/β-catenin signaling pathway. Previously, we reported that canonical Wnt signaling functions in a positive feedback loop with the DPAGT1 gene, a principal regulator of the metabolic pathway of protein N-glycosylation, to hyperglycosylate E-cadherin and reduce intercellular adhesion. Here, we show that in OSCC, DPAGT1 and canonical Wnt signaling converge to up-regulate CTHRC1 (collagen triple helix repeat containing 1), an N-glycoprotein implicated in tumor invasion and metastasis. We found that in human OSCC specimens, amplification of the levels of CTHRC1 was associated with its hyperglycosylation. Partial inhibition of DPAGT1 expression in OSCC CAL27 cells reduced CTHRC1 abundance by increasing protein turnover, indicating that N-glycosylation stabilizes CTHRC1. Additionally, canonical Wnt signaling promoted β-catenin/T-cell factor transcriptional activity at the CTHRC1 promoter to further elevate CTHRC1 levels. We demonstrate that DPAGT1 promotes cell migration and drives the localization of CTHRC1 to cells at the leading edge of a wound front coincident with drastic changes in cell morphology. We propose that in OSCC, dysregulation of canonical Wnt signaling and DPAGT1-dependent N-glycosylation induces CTHRC1, thereby driving OSCC cell migration and tumor spread.

Entities:  

Keywords:  CTHRC1; Cancer; Canonical Wnt; Cell Migration; DPAGT1; Glycoprotein; Glycosylation; OSCC; Wnt Signaling

Mesh:

Substances:

Year:  2013        PMID: 23703614      PMCID: PMC3711289          DOI: 10.1074/jbc.M113.473785

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors.

Authors:  Michael D Gordon; Roel Nusse
Journal:  J Biol Chem       Date:  2006-06-22       Impact factor: 5.157

2.  Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration.

Authors:  Peter Pyagay; Mélanie Heroult; Qiaozeng Wang; Wolfgang Lehnert; John Belden; Lucy Liaw; Robert E Friesel; Volkhard Lindner
Journal:  Circ Res       Date:  2004-12-23       Impact factor: 17.367

3.  Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex.

Authors:  Shinji Yamamoto; Osamu Nishimura; Kazuyo Misaki; Michiru Nishita; Yasuhiro Minami; Shigenobu Yonemura; Hiroshi Tarui; Hiroshi Sasaki
Journal:  Dev Cell       Date:  2008-07       Impact factor: 12.270

Review 4.  Towards an integrated view of Wnt signaling in development.

Authors:  Renée van Amerongen; Roel Nusse
Journal:  Development       Date:  2009-10       Impact factor: 6.868

5.  Rap1 stabilizes beta-catenin and enhances beta-catenin-dependent transcription and invasion in squamous cell carcinoma of the head and neck.

Authors:  Mitsuo Goto; Raj S Mitra; Min Liu; Julia Lee; Bradley S Henson; Thomas Carey; Carol Bradford; Mark Prince; Cun-Yu Wang; Eric R Fearon; Nisha J D'Silva
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

6.  Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.

Authors:  Fan Yang; Qinghua Zeng; Guangyan Yu; Shenglin Li; Cun-Yu Wang
Journal:  Cell Signal       Date:  2005-08-09       Impact factor: 4.315

Review 7.  Molecular biology of squamous cell carcinoma of the head and neck.

Authors:  B Perez-Ordoñez; M Beauchemin; R C K Jordan
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

8.  A novel glycosylation signal regulates transforming growth factor beta receptors as evidenced by endo-beta-galactosidase C expression in rodent cells.

Authors:  Satoshi Watanabe; Masako Misawa; Takashi Matsuzaki; Takayuki Sakurai; Takashi Muramatsu; Masahiro Sato
Journal:  Glycobiology       Date:  2010-11-09       Impact factor: 4.313

9.  Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

Authors:  Valbona Luga; Liang Zhang; Alicia M Viloria-Petit; Abiodun A Ogunjimi; Mohammad R Inanlou; Elaine Chiu; Marguerite Buchanan; Abdel Nasser Hosein; Mark Basik; Jeffrey L Wrana
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

10.  Coordinate regulation of N-glycosylation gene DPAGT1, canonical Wnt signaling and E-cadherin adhesion.

Authors:  Pritam K Sengupta; Meghan P Bouchie; Mihai Nita-Lazar; Hsiao-Ying Yang; Maria A Kukuruzinska
Journal:  J Cell Sci       Date:  2012-11-23       Impact factor: 5.285

View more
  26 in total

1.  Extracellular Matrix Glycoprotein-Derived Synthetic Peptides Differentially Modulate Glioma and Sarcoma Cell Migration.

Authors:  Nicole Brösicke; Muhammad Sallouh; Lisa-Marie Prior; Albert Job; Ralf Weberskirch; Andreas Faissner
Journal:  Cell Mol Neurobiol       Date:  2015-03-18       Impact factor: 5.046

2.  Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response.

Authors:  Jung-Tsu Chen; Chein-Hung Chen; Ko-Li Ku; Michael Hsiao; Chun-Pin Chiang; Tsui-Ling Hsu; Min-Huey Chen; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

3.  Inhibition of N-Glycosylation towards Novel Anti-Cancer Chemotherapeutics.

Authors:  Michio Kurosu
Journal:  J Mol Pharm Org Process Res       Date:  2018-01-12

4.  Identification of potential glycoprotein biomarkers in oral squamous cell carcinoma using sweet strategies.

Authors:  Yin-Ling Wong; Ramanathan Anand; Kar Mun Yuen; Wan Mahadzir Wan Mustafa; Mannil Thomas Abraham; Keng Kiong Tay; Zainal Ariff Abdul Rahman; Yeng Chen
Journal:  Glycoconj J       Date:  2021-02-06       Impact factor: 2.916

5.  Collagen triple helix repeat containing 1 is a new promigratory marker of arthritic pannus.

Authors:  Mohammed Talha Shekhani; Toni S Forde; Altynai Adilbayeva; Mohamed Ramez; Askhat Myngbay; Yergali Bexeitov; Volkhard Lindner; Vyacheslav A Adarichev
Journal:  Arthritis Res Ther       Date:  2016-07-19       Impact factor: 5.156

6.  Elevated plasma levels of the pituitary hormone Cthrc1 in individuals with red hair but not in patients with solid tumors.

Authors:  Christine W Duarte; J Patrizia Stohn; Qiaozeng Wang; Ivette F Emery; Andrew Prueser; Volkhard Lindner
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

Review 7.  Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling.

Authors:  Xaralabos Varelas; Meghan P Bouchie; Maria A Kukuruzinska
Journal:  Glycobiology       Date:  2014-04-17       Impact factor: 4.313

8.  Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.

Authors:  Chia Ee Lee; Vui King Vincent-Chong; Anand Ramanathan; Thomas George Kallarakkal; Lee Peng Karen-Ng; Wan Maria Nabillah Ghani; Zainal Ariff Abdul Rahman; Siti Mazlipah Ismail; Mannil Thomas Abraham; Keng Kiong Tay; Wan Mahadzir Wan Mustafa; Sok Ching Cheong; Rosnah Binti Zain
Journal:  Int J Med Sci       Date:  2015-11-01       Impact factor: 3.738

9.  CTHRC1 promotes angiogenesis by recruiting Tie2-expressing monocytes to pancreatic tumors.

Authors:  Jaemin Lee; Jinhoi Song; Eun-Soo Kwon; Seongyea Jo; Min Kyung Kang; Yeon Jeong Kim; Yeonsil Hwang; Hosung Bae; Tae Heung Kang; Suhwan Chang; Hee Jun Cho; Song Cheol Kim; Seokho Kim; Sang Seok Koh
Journal:  Exp Mol Med       Date:  2016-09-30       Impact factor: 8.718

10.  High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.

Authors:  Minzhi Hou; Zhiqiang Cheng; Hongwei Shen; Shanyang He; Yang Li; Yunping Pan; Chongjin Feng; Xinlin Chen; Yang Zhang; Millicent Lin; Liantang Wang; Zunfu Ke
Journal:  Oncotarget       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.